We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App





UV-C Light Kills SARS-CoV-2 Virus Within Seconds of Exposure in Lab Study

By HospiMedica International staff writers
Posted on 23 Jun 2020
Print article
Image: UV-C Light Kills SARS-CoV-2 Virus Within Seconds of Exposure in Lab Study (Photo courtesy of Signify)
Image: UV-C Light Kills SARS-CoV-2 Virus Within Seconds of Exposure in Lab Study (Photo courtesy of Signify)
A UV-C lighting technology developed by Signify (Eindhoven, The Netherlands) has proven to be effective in inactivating the SARS-CoV-2 virus in research studies.

In tests conducted by Signify, together with the National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University (Boston, MA, USA), the SARS-CoV-2 virus could no longer be detected after seconds of exposure to UV-C light sources. During their research, the scientists treated inoculated material with different doses of UV-C radiation coming from a Signify light source and assessed the inactivation capacity under various conditions. The team applied a dose of 5mJ/cm2, resulting in a reduction of the SARS-CoV-2 virus of 99% in six seconds. Based on the data, it was determined that a dose of 22mJ/cm2 will result in a reduction of 99.9999% in 25 seconds.

I’m very happy about the fruitful cooperation with Boston University in the fight against the coronavirus. Boston University has validated the effectiveness of our light sources as a preventive measure for companies and institutions as they seek ways to provide virus-free environments,” said Eric Rondolat, CEO of Signify. “Given the potential of the technology to aid the fight against the coronavirus, Signify will not keep the technology for its exclusive use but make it available to other lighting companies. To service the growing need for disinfection we will increase our production capacity multifold in the coming months.”

“Our test results show that above a specific dose of UV-C radiation, viruses were completely inactivated: in a matter of seconds we could no longer detect any virus,” said Dr. Anthony Griffiths, Associate Professor of Microbiology at Boston University School of Medicine. “We’re very excited about these findings and hope that this will accelerate the development of products that can help limit the spread of COVID-19.”

Related Links:
Signify
Boston University


Gold Member
12-Channel ECG
CM1200B
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
24.5-inch Full HD 2D OLED Medical Monitor
PVM-2551MD

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.